Ligand validation:6JUH

MC3: 1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE

MC3 is a Ligand Of Interest in 6JUH designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6JUH_MC3_B_1302	21%	19%	0.222	0.927	1.65	1.78	3	2	0	0	46%	0.4565
6JUH_MC3_A_1301	20%	20%	0.217	0.92	1.87	1.54	4	2	1	0	46%	0.4565
6JUH_MC3_C_1302	15%	20%	0.235	0.897	1.76	1.65	2	3	1	0	46%	0.4565
6JUH_MC3_D_1302	14%	17%	0.251	0.9	1.76	1.83	2	2	0	0	46%	0.4565
5KLB_MC3_D_1305	50%	19%	0.199	0.965	1.67	1.81	4	6	1	0	91%	0.913
5KMF_MC3_C_1305	28%	58%	0.136	0.929	0.9	0.7	-	-	0	0	22%	0.2174
5KMD_MC3_D_1303	22%	53%	0.144	0.903	0.96	0.86	1	-	0	0	22%	0.2174
5KMH_MC3_A_1306	19%	37%	0.212	0.947	1.08	1.39	1	2	0	0	22%	0.2174
2XTV_MC3_A_501	52%	42%	0.13	0.935	1.18	1.09	3	4	1	0	74%	0.7391
4C00_MC3_A_611	49%	50%	0.196	0.954	0.95	0.97	1	4	0	0	93%	0.9348

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.